In other studies comparing fewer than 10 pairs of primary and CM tumor, specific variations in CM included ATR, BRCA1, SMAD4, CDH1, ARID1A, ERBB2, IDH1, PIK3R1, RB1, and others, such as amplification of FGFR1/structural variant of TP53, indel of RB1/amplification of TERT, JAK2, NF1, TP53, AKT1 and ARID1A, PIK3CA, TP53, and others [11, 12, 15]. This evidence concerns the gene FGFR1 and neoplasm.